681448-25-9

Basic information

• Product Name: (4,4-Dimethyl-cyclohexyl)-acetic acid
• Synonyms: (4,4-Dimethyl-cyclohexyl)-acetic acid;2-(4,4-Dimethylcyclohexyl)acetic acid
• CAS NO: 681448-25-9
• Molecular Formula: C₁₀H₁₈O₂
• Molecular Weight: 170.24872
• EINECS: -0
• Mol File: 681448-25-9.mol

Chemical Properties

• Boiling Point: 266.4±8.0 °C(Predicted)
• Appearance: /
• Density: 0.961±0.06 g/cm3(Predicted)
• PKA: 4.72±0.10(Predicted)
• CAS DataBase Reference: (4,4-Dimethyl-cyclohexyl)-acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (4,4-Dimethyl-cyclohexyl)-acetic acid(681448-25-9)
• EPA Substance Registry System: (4,4-Dimethyl-cyclohexyl)-acetic acid(681448-25-9)

Safety Data

• Hazardous Substances Data: 681448-25-9(Hazardous Substances Data)

Usage

General Description

(4,4-Dimethyl-cyclohexyl)-acetic acid is a chemical compound with the molecular formula C10H18O2. It is a carboxylic acid with a cyclohexyl ring substituted with two methyl groups. (4,4-Dimethyl-cyclohexyl)-acetic acid is used in the synthesis of pharmaceuticals and agrochemicals. It has also been studied for its potential anti-inflammatory and analgesic properties. Additionally, (4,4-Dimethyl-cyclohexyl)-acetic acid has been used in the production of fragrance and flavoring agents. It is important to handle this chemical with caution as it may cause skin and eye irritation, and it should be stored in a cool, dry place and kept away from sources of ignition.

Relevant articles and documents

SUBSTITUTED AMINOTHIAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE

Substituted aminothiazole derivatives, methods of their preparation, pharmaceutical compositions comprising a substituted aminothiazole, and methods of use in treating human or animal disorders. The compounds may be useful as inhibitors of action of AgRP on a melanocortin receptor and thus may be useful for the management, treatment, control, or the adjunct treatment of diseases which may be responsive to the modulation of melanocortin receptors including obesity-related disorders.

Cycloalkylamides and their therapeutic applications

The present invention relates to the use of compounds of formula (I) for the treatment of a variety of disorders including, but not limited to, epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, neuroprotection, and movement disorders.

Cycloalkylamides and their therapeutic applications

The present invention relates to the use of compounds of formula (I) for the treatment of a variety of disorders including, but not limited to, epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, neuroprotection, and movement disorders.